John W. Davis, MD, PhD, Resident, WashU Medicine Department Medicine, has been selected for a JACC: Heart Failure Top Peer Reviewer Award. The award was presented at the American College of Cardiology’s Annual Scientific Session (ACC.26) in New Orleans, recognizing outstanding peer reviewers for the journal during the past year.
Davis is one of 20 reviewers worldwide chosen for the honor, which is bestowed by the editors of JACC: Heart Failure — a subspecialty journal in the JACC family, the flagship journals of the American College of Cardiology. Selection is based on the consistent quality, rigor, and timeliness of manuscript reviews. Davis was recognized for his reviews in epidemiologic study design and comparative effectiveness and outcomes research, areas central to advancing the evidence base for heart failure care.
“It’s a real honor to be recognized alongside such an accomplished group of reviewers. Peer review is where the scientific rigor of a field is quietly upheld, and I’m grateful for the opportunity to contribute to JACC: Heart Failure’s mission of advancing evidence-based heart failure care. I look forward to continuing this work as I develop my own research program in heart failure outcomes and point-of-care diagnostics.”
The JACC family of journals is among the most widely read and highly cited sources in cardiovascular medicine. Peer reviewers are essential to maintaining the quality and integrity of the science we publish, offering independent expert evaluations that help determine which findings reach clinicians and ultimately impact patient care. The Top Peer Reviewer recognition honors those whose exceptional contributions significantly enhance the journal’s editorial process and scientific rigor.
In addition to his clinical training, Davis serves as an Associate Editor at Clinical Cardiology and holds two patents on novel point-of-care ultrasound methods for the management of acute heart failure. His scholarly work bridges clinical epidemiology, outcomes research, and bedside innovation, with a focus on improving how acute heart failure is diagnosed and managed in real-world settings.